An early introduction of USK (median time 12 months) has been reported by Hasan [27], and the analysis limited to patients treated with biologic in the first 4 years after cancer diagnosis did not find any difference between USK, VDZ, anti-TNFα, and controls. The gene discussed is TNF; the disease is cancer.